Can the DIO2 CT genotype alter tissue thyroid hormone signaling relevant to mitochondrial function?

The DIO2 Thr92Ala polymorphism (rs225014), represented by the CT and CC genotypes, plays a critical role in modulating tissue-specific thyroid hormone action and cellular metabolism.

Intracellular signaling and enzyme kinetics

• Reduced D2 Activity: The CT genotype reduces type 2 deiodinase (D2) catalytic activity by 20% to 40%. This impairs the crucial intracellular conversion of thyroxine (T4) to active triiodothyronine (T3).
• Localized Deprivation: Because tissues such as the brain, skeletal muscle, and brown adipose tissue rely heavily on local deiodination, carriers experience localized tissue-level thyroid hormone deprivation, even when circulating serum thyroid levels appear completely normal.

Mechanistic impact on mitochondrial function

• Blunted Mitochondrial Biogenesis: Local T3 signaling is an essential driver of mitochondrial biogenesis, oxidative phosphorylation, and adaptive thermogenesis. Reduced local signaling directly compromises mitochondrial respiration and energy production.
• ER and Golgi Stress Pathways: The altered Ala92-D2 protein abnormally accumulates in the Golgi apparatus. This mislocalization triggers endoplasmic reticulum (ER) and Golgi stress.
• Mitochondrial Unbalancing: The resulting cellular stress response, coupled with deficient T3 signaling, initiates an unfolded protein response, increasing oxidative stress and disrupting downstream mitochondrial energetics.

Bottom line

• The DIO2 CT genotype alters local tissue thyroid signaling by reducing D2 catalytic activity by 20% to 40% and inducing ER/Golgi stress, collectively impairing mitochondrial function and promoting localized metabolic and oxidative inefficiency.